Page 45 - Anjali Singh

Health tech startup Neodocs raises Rs 16.6 cr in seed funding round

Company that makes smartphone-based medical test kits will use the financing to expand business

Declining raw material prices help to boost tyre makers' profitability

Among raw materials used by the tyre industry, Brent crude oil prices saw a 6 per cent drop year-on-year

JK Tyre and Industries Q3 results: Profit rises three-fold to Rs 221 cr

On a sequential basis, the company exhibited a 5.39 per cent decline in revenue along with PAT, which also declined by 8.79 per cent. The EBITDA grew by 61 per cent year-on-year, reaching Rs 563 crore

Entero Healthcare Solutions set to launch Rs 1,600-crore IPO on February 9

In FY23, Entero Healthcare reported Rs 33,00.20 crore in revenue from operations with a gross profit of Rs 268.34 crore

Alembic Pharma Q3 results: Profit up 48% as raw material cost declines

This increase in PAT was attributed to tax deduction, decline in the cost of materials consumed, and improvement in Ebitda

Thyrocare acquires Think Health Diagnostics, expands into home ECG services

With this strategic acquisition, Thyrocare will expand its footprint in the pre-policy medical check-up segment for the insurance market

Metropolis Healthcare Q3 results: PAT down 24% due to Chennai floods

On a sequential basis, the company exhibited a 5.63 per cent decline in revenue along with PAT, which declined by 23.41 per cent

Torrent Pharma Q3 results: Profit after tax up 51% at Rs 443 crore

Torrent Pharmaceuticals' share price rose by 0.51 per cent, ending the day's trade at Rs 2,524 apiece on the Bombay Stock Exchange (BSE)

Glenmark, Pfizer launch Abrocitinib in India for Atopic Dermatitis

The prevalence of atopic dermatitis in India has risen over the past three decades, with approximately 5.9 per cent of adults affected, of which 4.4 per cent suffer from a severe form of the disease

Dr Reddy's Lab Q3 results: Net profit rises 11% on strong US, EU sales

For the Indian business in Q3 FY24, the revenue stood at Rs 1,180 crore Y-o-Y with a growth of 5 per cent and a sequential decline of 1 per cent

Piramal Pharma Q3FY24 results: Company posts profit at Rs 19.3 crore

On a sequential basis, the company exhibited a 2.47 percent increase in revenue whereas the PAT declined by 51.07 percent

AI adoption in healthcare to create almost 3 mn jobs by 2028: Report

Demand will be for data scientists, developers and cybersecurity specialists, it says

AstraZeneca to import critical drugs to India, focus on cancer therapies

AstraZeneca is currently conducting 50 clinical trials in India

Jubilant Pharma to sell stake in Sofie Biosciences for $139.43 million

Jubilant Pharma had invested $25 million in Sofie Biosciences in November 2020 and now plans to exit its investment completely

Glenmark expands global reach with cancer drug Envafolimab agreement

Envafolimab is a first-in-class PD-L1 inhibitor, a type of immunotherapy drug that harnesses the body's immune system to fight cancer

Kinetic Green to launch E-Luna in February, bookings start on January 26

Consumers can secure their E-Luna by pre-booking on the Kinetic Green website for an amount of Rs 500. Kinetic had started a pilot around September in some locations of Maharashtra

Ceat Q3 PAT rises 5-fold as margin pressure eases, reaches Rs 181.48 cr

Ceat's share price rose by 4.34 per cent, ending the day's trade at Rs 2,875 apiece on the BSE

Lupin secures a tentative USFDA approval for Rivaroxaban tablets

Lupin boasts 15 manufacturing sites, 7 research centres, and a global team of more than 20,000 professionals

Ather Energy announces its new family-oriented electric scooter 'Rizta'

Despite the shift towards a family-centric approach, Mehta assured customers that the Rizta will uphold the quality and reliability synonymous with the Ather brand

Tata Motors announces 0.7% price hike on passenger vehicles from Feb 1

The automotive industry has witnessed a trend, with various manufacturers resorting to similar price hikes in the early months of FY24